DexCom, Inc.
DXCMNASDAQHealthcare● Active
$76.62
+$3.76(+5.16%)
Market Cap$29.6B
P/E Ratio—
52W High$89.98
52W Low$54.11
DexCom, Inc.（DXCM）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · DXCM · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.84B | $0.58B | $0.54B | $0.34B | $0.15B |
| Depreciation & Amort. | $0.25B | $0.22B | $0.19B | $0.16B | $0.10B |
| Stock-Based Comp. | $0.16B | $0.17B | $0.15B | $0.13B | $0.11B |
| Change in Working Capital | $0.10B | $0.11B | $0.00B | $0.03B | ($0.13B) |
| Net Cash from Operations | $1.44B | $0.99B | $0.75B | $0.67B | $0.44B |
| Investing Activities | |||||
| Capital Expenditure | ($0.36B) | ($0.36B) | ($0.24B) | ($0.36B) | ($0.39B) |
| Purchases of Investments | ($1.27B) | ($2.66B) | ($3.20B) | ($2.27B) | ($2.47B) |
| Sales of Investments | $2.16B | $2.82B | $2.95B | $2.13B | $2.67B |
| Net Cash from Investing | $0.54B | ($0.21B) | ($0.51B) | ($0.52B) | ($0.22B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.50B) | ($0.75B) | ($0.69B) | ($0.56B) | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | ($1.21B) | $0.00B | $0.44B | $0.00B | $0.00B |
| Net Cash from Financing | ($1.69B) | ($0.73B) | ($0.32B) | ($0.55B) | $0.01B |
| Free Cash Flow | |||||
| Free Cash Flow | $1.08B | $0.63B | $0.51B | $0.30B | $0.05B |
| FCF Margin %(computed) | 23.11% | 15.64% | 14.13% | 10.47% | 2.18% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解DexCom, Inc.
关于DexCom, Inc.（DXCM）现金流量表
DexCom, Inc. 2025财年经营活动现金流$1.44B，自由现金流$1.08B（FCF利润率23.11%），资本支出($0.36B)。
常见问题
DXCM · 4 问DexCom, Inc. 2025财年自由现金流$1.08B，同比up70.8%。
DXCM free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10